A major problem in Central and South America, Chagas disease is now also affecting individuals residing in other parts of the world. Many patients with late-stage disease have chronic cardiomyopathy and associated arrhythmias. In this Perspectives article, Professor Benaim and Dr Paniz Mondolfi discuss the potential for amiodarone and dronedarone to be used as dual-action (antiarrhythmic and antiparasitic) agents in patients with Chagas disease.
- Gustavo Benaim
- Alberto E. Paniz Mondolfi
